LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...
Cochlear Limited ((CHEOF)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...
Cochlear reaffirmed guidance for FY 2025 underlying net profit between $410 million and $430 million, though it expects to achieve the lower end of this range. The revision is driven by weaker ...
The Nucleus 8 Sound Processor is the world's first cochlear implant sound processor ready for Bluetooth LE Audio technology Experience the full interactive ...
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to ...
LONE TREE, Colo., Jan. 11, 2022 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) approval of Cochlear™ ...
Individuals with UHL/SSD can now seek treatment with a cochlear implant from Cochlear to hear with both ears. Cochlear Limited obtained U.S. Food and Drug Administration (FDA) approval of Cochlear™ ...
NEW YORK, Aug. 8, 2024 /PRNewswire/ -- The global cochlear implants market size is estimated to grow by USD 975.3 million from 2024-2028, according to Technavio. The market is estimated to grow at a ...
SYDNEY, Sept 12 (Reuters) - Australian hearing implant maker Cochlear Limited said on Monday it was undertaking a voluntary recall of the unimplanted Nucleus CI500 implant range, with the financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results